The Spectacular, Brief Life of a Cure

The Spectacular, Brief Life of a Cure

Over the last decade, observers of the US pharmaceutical market witnessed something remarkable.


The Patent Cliff: Analytical Instruments Climb as Pharmaceuticals Face a Long Descent

The Patent Cliff: Analytical Instruments Climb as Pharmaceuticals Face a Long Descent

US demand for analytical instruments is forecast to total $50.2 billion in 2021. Much of this increased demand stems from the need for pharmaceutical companies to produce novel drugs in the face of a laundry list of expiring patents in the coming months and years. Without new pharmaceutical developments, companies’ profits will plummet as their blockbuster medications are exposed to competition from third parties producing generic formulations.